Search

everythinglearnresearchcommunity

for

Search:↓

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Advanced imaging techniques are crucial for accurately diagnosing Monilethrix, a rare hair disorder.

The CWARTS tool is a promising method for assessing warts and could improve treatment and research.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

A 47-year-old man's eyelid swelling didn't improve with basic treatments, so a biopsy was needed.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Treat hair loss in postmenopausal women with diet, avoiding certain drugs, and using medications like minoxidil or finasteride.

A girl with symptoms like an autoimmune disorder actually had HIV and a fungal infection, which was hard to diagnose and treat, leading to her death.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

Upcoming pediatric dermatology events and submission guidelines were announced.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

Older age, family history, and low iron levels increase the risk of female hair loss.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Genetic testing confirmed a young girl has Atrichia with Papular Lesions due to mutations in the hairless gene.

Two sisters have rare hair disorders causing short, fragile, kinky hair.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Two women experienced temporary hair loss and other side effects from imiquimod treatment for cervical issues, which stopped after ending the treatment.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Higher levels of miR-203 may contribute to hair loss in alopecia areata.

We need better research to improve alopecia treatment and patient care.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.